| Course | HEA-3050 Women's Health |
|---|---|
| Module | Module 6 |
| Paper type | Health education plan: cervical cancer prevention |
| Length | About 1,044 words, 6 pages |
| Format | APA 7 student paper |
| School | Thomas Edison State University |
| Program | B.S. in Health Studies |
| Updated | October 2026 |
Free sample paper for HEA 3050 Module 6
One Disease We Can Nearly Prevent: Planning HPV and Screening Education at a Paramus Community College
Student Name
B.S. in Health Studies, Thomas Edison State University
HEA-3050: Women's Health
Mentor Name
Month Day, Year
One Disease We Can Nearly Prevent: Planning HPV and Screening Education at a Paramus Community College
Introduction
Cervical cancer was once a leading cause of cancer death among American women. Regular screening reduced it dramatically, and vaccination against human papillomavirus, the virus that causes nearly all cervical cancers, now offers prevention before infection. Yet many young women are not vaccinated and do not know when to begin screening or how often to repeat it. This paper plans an education program for a community college whose students are mostly 18 to 26, the ages at which both messages matter.
The Setting and Audience
The college is invented for this paper. It enrolls about 8,000 students in Paramus, many of them working part time, first in their families to attend college or recent immigrants from Latin America and South Korea. The college's health office has one nurse and a part-time health educator. A student survey found that many women had not heard of the HPV vaccine or thought it was only for teenagers, and that few knew when screening should start.
How Cervical Cancer Develops
Persistent infection with high-risk types of HPV, which is spread through sexual contact, can cause cell changes on the cervix that may progress over years to cancer. Most infections clear on their own. Screening finds precancerous changes so they can be treated, and vaccination prevents infection with the types that cause most cancers.
Screening Guidance
For women aged 21 to 29, the Task Force recommended cervical cytology, the Pap test, every three years (US Preventive Services Task Force, 2018). For women aged 30 to 65, it allowed three options: cytology on a three-year cycle, high-risk HPV testing alone, repeated every five years, or cotesting with both tests together on the same five-year schedule. It recommended against screening women younger than 21, women over 65 whose earlier screening was adequate and who carry no special risk and women who have had a hysterectomy with removal of the cervix and no history of high-grade precancer or cancer.
Evidence on Vaccination
Lei et al. (2020) linked vaccination and cancer registries for close to 1.7 million Swedish females between 10 and 30 years old, from 2006 to 2017. After adjustment for other factors, the cancer rate among those vaccinated before their seventeenth birthday was roughly 88 percent below that of the unvaccinated, and those vaccinated at 17 to 30 also had a substantially lower rate. This was the first population study to show reduced invasive cancer, not only precancer.
Falcaro et al. (2021) studied England's national program, which offered vaccination to girls at 12 to 13 from 2008 with catch-up for older girls. Cervical cancer rates were about 87 percent lower in women offered vaccination at 12 to 13 than in earlier unvaccinated groups, with smaller reductions in those vaccinated at older ages. The authors concluded that the program had almost eliminated cervical cancer in women born since September 1995.
| Source | Key finding | Program message |
|---|---|---|
| US Preventive Services Task Force (2018) | Screen from 21 to 65 at set intervals | Start at 21; know your interval |
| Lei et al. (2020) | Vaccination before 17 linked to 88 percent less cancer | Vaccination prevents cancer, not just infection |
| Falcaro et al. (2021) | Largest drop with vaccination at 12 to 13 | Earlier is better, but later still helps |
Program Goals and Messages
The program has two goals: raise HPV vaccination among students aged 18 to 26 who have not completed the series and increase the share of women aged 21 and older who know their screening interval and are up to date. Messages are short: the HPV vaccine prevents cancer; it is recommended through age 26; screening starts at 21 and repeats every three years until 30; and screening is still needed after vaccination, because the vaccine does not cover every cancer-causing type.
Delivery
The program uses channels students already use. The health office will run short sessions during orientation and in the college's first-year seminar, post brief videos on the college's social media in English, Spanish and Korean and add a vaccination check to the existing health form. Partnerships with the county health department and a federally qualified health center will offer vaccination on campus twice each semester and low-cost screening for uninsured students. Student peer educators, trained by the health educator, will staff tables at events.
Cultural and Personal Influences
Some students may be uncomfortable discussing a sexually transmitted virus, and some parents may worry that vaccination encourages sexual activity, a concern research has not supported. Messages will focus on cancer prevention, and sessions will respect privacy. Recent immigrants may not know U.S. screening schedules, and translated materials will address this. Students without insurance will learn about free and low-cost options.
Evaluation
The college will measure vaccination series started and completed at campus clinics, compare survey knowledge before and after the program and count screening referrals. A comparison of results by language group will show whether the program reaches all students equally.
Objectives
Each goal needs a measurable objective. By the end of the academic year, the program aims to start the vaccine series for 300 students aged 18 to 26 who were not fully vaccinated and complete the series for at least two thirds of them. It also aims to raise the share of women aged 21 and older who can state when screening should start and how often it should repeat from the baseline found in the student survey to at least three in four. Objectives like these let the college judge whether the program worked rather than whether it was delivered.
Limits
The vaccination studies were observational, though very large, and come from countries with national health systems and registries. Their results may not translate exactly to American students vaccinated in their twenties. Screening guidance may change as HPV testing replaces cytology, so the program will review its messages each year.
Conclusion
Few cancers can be prevented as reliably as cervical cancer. The Task Force set clear screening intervals, and population studies in Sweden and England showed that vaccination prevents invasive cancer, most of all when given early. For students in Paramus who missed vaccination as teenagers, a program that uses the channels they already use, in the languages they speak, can close the gap.
References
Falcaro, M., Castañon, A., Ndlela, B., Checchi, M., Soldan, K., Lopez-Bernal, J., Elliss-Brookes, L., & Sasieni, P. (2021). The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study. The Lancet, 398(10316), 2084-2092. https://doi.org/10.1016/S0140-6736(21)02178-4
Lei, J., Ploner, A., Elfström, K. M., Wang, J., Roth, A., Fang, F., Sundström, K., Dillner, J., & Sparén, P. (2020). HPV vaccination and the risk of invasive cervical cancer. New England Journal of Medicine, 383(14), 1340-1348. https://doi.org/10.1056/NEJMoa1917338
US Preventive Services Task Force. (2018). Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA, 320(7), 674-686. https://doi.org/10.1001/jama.2018.10897
HEA 3050 Module 6 instructions, in plain terms
Healthy choices and risk factors are among the topics TESU names for HEA-3050, and with no syllabus made public, module six is planned as a health education plan on cervical cancer prevention. A plan of this kind describes the setting and audience, explains how the disease develops, states current screening guidance accurately, summarizes evidence on vaccination, turns evidence into clear messages, describes delivery that fits real resources, addresses cultural and personal influences and sets measurable evaluation. Some sections ask for a plan on breast cancer screening or on sexually transmitted infections instead. Check whether the brief requires SMART objectives and a budget. Mentors usually expect measurable objectives with numbers and dates, so write them before planning activities. Note where your setting differs from the countries in the vaccine studies.
Inside the HEA 3050 Module 6 example
An invented community college in Paramus, with one nurse and a part-time educator, opens the paper with a survey of students' gaps. The path from HPV infection to cancer, the 2018 screening intervals and the Swedish and English vaccination studies are explained, then turned into plain messages in a table. Goals, delivery through orientation, social media in three languages and campus clinics with partners, cultural concerns about a sexually transmitted virus and an evaluation by language group follow. A conclusion calls cervical cancer one of the most preventable cancers. Measurable objectives for vaccine series and screening knowledge and a limits section on observational evidence and changing guidance come before the conclusion.
Reading the HEA 3050 Module 6 grading rubric
Health education plans earn credit for a clearly described audience, accurate disease background, current screening guidance with ages and intervals, vaccination evidence reported with its population and limits, messages that follow from evidence, delivery that fits the setting, attention to cultural and personal influences and measurable evaluation. A reminder that vaccinated women still need screening is the kind of detail mentors reward. Planning for uninsured students and translated materials shows equity awareness. Reference titles keep their original spelling as published. Objectives with numbers and dates let the reader judge success. Acknowledging that vaccine studies came from countries with national registries shows care in applying evidence to American students.
Common HEA 3050 Module 6 mistakes, and how to avoid them
Education plans often list facts without turning them into messages; write what you want students to do. Another frequent gap is stating screening guidance without ages and intervals. Describe your audience. Use current guidance. Report vaccine evidence with its limits. Choose channels your audience uses. Plan for language and cost. Measure results. Tell us your setting, and a free first draft of the plan follows your brief. Write objectives with numbers and a deadline. Explain why screening continues after vaccination. Plan to review messages as guidance changes. Keep materials short and translated. Say who will deliver each activity.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Thomas Edison State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More HEA 3050 and B.S. in Health Studies sample papers
- HEA 3050 Module 1: Women in Clinical Research Paper: From Exclusion to the 1993 Inclusion Law
- HEA 3050 Module 2: Maternal Mortality Paper: Racial Disparities in Pregnancy-Related Deaths
- HEA 3050 Module 3: Menopause Paper: Hormone Therapy Decisions After the Women's Health Initiative
- HEA 3050 Module 4: Intimate Partner Violence Paper: What Screening in Clinics Can and Cannot Do
- HEA 3050 Module 5: Perinatal Depression Paper: Prevalence, Screening and Counseling to Prevent It
- SOS 3700 Module 4: Final Project Background Draft: SNAP Restrictions
- HEA 3071 Module 4: Heart Failure Case Study: Neurohormones, Remodeling and the Drugs That Reverse Them
- HEA 3060 Module 3: Men's Depression and Suicide Paper: How Distress Is Missed and What Prevents Deaths
- SOS 3200 Module 2: Stress Response Paper: From Selye's Alarm Reaction to Allostatic Load and Immunity
HEA 3050 Module 6 questions, answered
Where can I find a free HEA 3050 Module 6 sample paper?
The cervical cancer prevention plan for an invented Paramus community college, from screening intervals to HPV vaccination, appears in full on this page.
When should cervical cancer screening start?
At age 21, with a Pap test every three years until 30, according to the 2018 Task Force recommendation.
How often should women aged 30 to 65 be screened?
Every three years with a Pap test, every five years with HPV testing alone or every five years with both.
Does HPV vaccination prevent cervical cancer?
Yes; Swedish women vaccinated before 17 developed invasive cervical cancer about 88 percent less often than unvaccinated women.
Do vaccinated women still need screening?
Yes; the vaccine does not cover every cancer-causing HPV type, so regular screening continues.